BioLine RX Ltd (BLRX) — Cash Flow Quality Index
BioLine RX Ltd (BLRX) has a Cash Flow Quality Index of -0.51x as of March 2025. Operating cash flow of ILA-2.59 Million is below net income of ILA5.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BioLine RX Ltd (BLRX) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioLine RX Ltd Cash Flow Quality Index (2010–2010)
Historical Cash Flow Quality Index for BioLine RX Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BioLine RX Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BioLine RX Ltd (2010–2010)
Year-by-year earnings quality comparison for BioLine RX Ltd. For live market cap and the full company financial profile, see BioLine RX Ltd stock valuation.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | 5.47x | ILA11.46 Million | ILA2.10 Million | — |